Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2005
10/06/2005WO2004072031A8 Phenylacetamides and their use as glucokinase modulators
10/06/2005US20050222414 N-(4-methylphenyl)-4-[4-[[(phenylmethoxy)amino]carbonyl]phenyl]-1-piperazinecarboxamide; anticarcinogenic, antiproliferative agent; ovarian carcinoma, psoriasis; gene transcription control
10/06/2005US20050222412 Antibiotic; bactericides
10/06/2005US20050222410 Inhibitors of histone deacetylase
10/06/2005US20050222247 Chroman derivatives
10/06/2005US20050222239 Pyrazole-amine compounds for the treatment of neurodegenerative disorders
10/06/2005US20050222237 Inhibitors of glycogen synthase kinase-3 (GSK-3), a serine/threonine protein kinase; for treatment and prevention of diabetes and Alzheimer's disease
10/06/2005US20050222236 Viral polymerase inhibitors
10/06/2005US20050222230 3,4-diarylpyrazoles and their use in the therapy of cancer
10/06/2005US20050222210 Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
10/06/2005US20050222207 Phosphodiesterase 4 inhibitors, including N-substituted diarylamine analogs
10/06/2005US20050222206 Pyridinoylpiperidines as 5-ht1f agonists
10/06/2005US20050222203 Nitrogen heterocycle biaryls for osteoporosis and other diseases
10/06/2005US20050222200 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
10/06/2005US20050222199 Process for the preparation of a hydrate of an antranilic acid derivative
10/06/2005US20050222186 Substituted diaminopyrimidines
10/06/2005US20050222159 2,3-dihydropyridazin-3-ones e.g. 3-amino-6-(1-isopropyl-6-oxo-1,6-dihydro-3-pyridazinyl)-5-phenyl-2-pyrazinecarboxamide; adenosine antagonists; depression, dementia, Parkinson's disease, anxiety, pain, hypertension, obesity, gout, bronchial asthma
10/06/2005US20050222152 Enzyme inhibitors for disease treatment with Cathepsin s
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005US20050222124 Benzenesulfonamide derivatives as antipsychotic agents
10/06/2005US20050222118 For therapy of inflammatory or allergic condition
10/06/2005US20050222056 Heterocyclic compounds and their use in the detection of nucleic acids
10/06/2005US20050221989 O-cyclopropyl-carboxanilides and their use as fungicides
10/06/2005US20050221318 Building block forming a c-c bond upon reaction
10/06/2005US20050221316 Method for synthesising templated molecules
10/06/2005CA2561066A1 Antiviral 4-aminocarbonylamino-substituted imidazole compounds
10/06/2005CA2561059A1 Process and intermediate compounds useful in the preparation of statins, particularly rosuvastatin
10/06/2005CA2560895A1 Acrylonitrile derivatives for inflammation and immune-related uses
10/06/2005CA2560485A1 Process for preparing n-aryl-piperazine derivatives
10/06/2005CA2560243A1 Pharmaceutical dosage forms and compositions of 5-ht1a receptor antagonists
10/06/2005CA2557798A1 Process for preparing cephalosporin intermediates using alpha-iodo-1-azetidineacetic acid esters and trialkylphosphites
10/06/2005CA2557745A1 Bicyclic substituted indole-derivative steroid hormone nuclear receptor modulators
10/05/2005EP1581518A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581517A1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581516A2 3-heterocyclic benzylamide derivatives as potassium channel openers
10/05/2005EP1581515A1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/05/2005EP1581505A1 Pyridazinone derivatives as gsk-3beta inhibitors
10/05/2005EP1581501A1 4-oxo-3-(1-oxo-1h-isoquinolin-2-ylacetylamino)-pentanoic acid ester and amide derivatives and their use as caspase inhibitors
10/05/2005EP1581499A1 Microsomal triglyceride transfer protein inhibitors
10/05/2005EP1581498A2 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
10/05/2005EP1581496A2 2-substituted-3-propenamide derivatives and methods of using the same
10/05/2005EP1581261A1 Cytotoxins and diagnostic imaging agents comprising hsp90 ligands
10/05/2005EP1581232A1 3-(3,5-dioxo-4,5-dihydro-3h-(1,2,4)triazin-2-yl)-benzamide derivatives as p2x7-inhibitors for the treatment of inflammatory diseases
10/05/2005EP1581207A2 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/05/2005EP1419154B1 Rapamycin 29-enols
10/05/2005EP1272168B1 Small organic molecule regulators of cell proliferation
10/05/2005EP1202733B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents
10/05/2005CN1678607A Nitrogen-containing aromatic ring derivatives
10/05/2005CN1678604A Novel benzoimidazole derivatives useful as antiproliferative agents
10/05/2005CN1678593A Microbiocidal (e.g. fungicidal) 1, 2, 3-triazole derivatives
10/05/2005CN1678589A Novel aminoindazole derivatives as medicaments and pharmaceutical compositions including them
10/05/2005CN1678587A CCK-1 receptor modulators
10/05/2005CN1678586A 取代的喹啉ccr5受体拮抗剂 Substituted quinoline ccr5 receptor antagonist
10/05/2005CN1678581A Indolin phenylsulfonamide derivatives
10/05/2005CN1678578A Indoles having anti-diabetic activity
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678315A Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
10/05/2005CN1676524A Anti plant virus agricultural cytosin peptidechycin, and its preparing process
10/05/2005CN1221539C Taxane derivs
10/05/2005CN1221537C Epimino substituted benzene derivative
10/05/2005CN1221536C New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl- pyrimidines, their preparation and application as medication
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221533C 7-amino-1H-indole derivatives
10/05/2005CN1221514C Intermediate for preparing alkyl-dihalogeno phenyl substituted keto-enol
10/04/2005US6951952 which exhibit a first color when in crystalline form and a second different color when in the liquid, amorphous form; for thermal imaging
10/04/2005US6951950 such as (3S)-3-(2-amino-2-oxo-1,1-diphenylethyl)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]-1-methylpyrrolidinium iodide for treatment of asthma, chronic obstructive pulmonary disorder, allergic rhinitis, and infectious rhinitis
10/04/2005US6951949 such as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for treatment of arthritis
10/04/2005US6951883 2H-1-benzopyran derivatives processes for their preparation and pharmaceutical compositions thereof
10/04/2005US6951882 treating obesity or a sleep/wake disorder mediated by orexin-2; antagonists
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951871 Indole derivatives useful as histamine H3 antagonists
10/04/2005US6951870 Ortho-diihydroxy- coumarin or 1,2--dihydroquinoline derivatives as catechol-O-methyltransferase enzyme inhibitors for Parkinson*s disease treatment
10/04/2005US6951866 Bicyclic pyrimidine compounds and therapeutic use thereof
10/04/2005US6951856 Substituted pyrimidine-sulfonamide derivatives are used as endothelin receptor antagonists
10/04/2005US6951852 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
10/04/2005US6951848 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
10/04/2005US6951713 Absorbing pathogen-inactivating compounds with porous particles immobilized in a matrix
10/04/2005CA2146763C Quinolone and acridinone derivatives for the treatment of urinary incontinence
09/2005
09/29/2005WO2005090337A1 Opioid receptor antagonists
09/29/2005WO2005090336A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
09/29/2005WO2005090335A1 Epothilone derivatives
09/29/2005WO2005090334A2 Processes and intermediates for the preparation of aspartic acetal caspase inhibitors
09/29/2005WO2005090333A1 3-‘4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
09/29/2005WO2005090332A1 Substituted quinazoline or pyridopyrimidine derivative
09/29/2005WO2005090330A1 N-piperidine derivates as ccr3 modulators
09/29/2005WO2005090329A1 New compounds for the inhibition of angiogenesis and use of thereof
09/29/2005WO2005090327A1 Indeno-fused photochromic naphthopyrans, naphthols and photochromic articles
09/29/2005WO2005090320A2 Triazole derivatives and method of using the same to treat hiv infections
09/29/2005WO2005090318A1 Novel amination process
09/29/2005WO2005090305A1 5-amino-4-hydroxy-7-(1h-indolmethyl)-8-methylnonamide derivatives as renin inhibitors for the treatment of hypertension
09/29/2005WO2005090303A1 4- (5- (aminomethyl) -indole-1-ylmethyl) -benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity
09/29/2005WO2005090300A1 Novel benzyl(idene)-lactam derivatives
09/29/2005WO2005090298A1 Sulphonamide derivatives
09/29/2005WO2005090297A1 Sulphonamide derivatives
09/29/2005WO2005089813A2 Receptor-avid exogenous optical contrast and therapeutic agents
09/29/2005WO2005089770A1 Benzodiazepines for treating or preventing or preventing rsv infection
09/29/2005WO2005089551A1 Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides
09/29/2005WO2005073224A3 Quinoline quinazoline pyridine and pyrimidine counds and their use in the treatment of inflammation angiogenesis and cancer
09/29/2005WO2005073195A3 Hcv ns-3 serine protease inhibitors
1 ... 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 ... 694